-
Document de presse | 2023.07.20
HIV: 20 months' remission after a bone marrow transplant with no protective mutation – the Geneva patient
In February 2023, the IciStem consortium, which includes Asier Sáez-Cirión's team at the Institut Pasteur, published details in Nature Medicine of a third case of HIV remission after a bone marrow transplant, involving the Düsseldorf patient. A total of 5 individuals (the Berlin, London, Düsseldorf, New York and City of Hope patients) are now considered as having probably been cured of HIV...
-
Document de presse | 2024.02.14
Smoking has long-term effects on the immune system
Like other factors such as age, sex and genetics, smoking has a major impact on immune responses. This is the finding recently made by a team of scientists at the Institut Pasteur using the Milieu Intérieur cohort of 1,000 healthy volunteers, established to understand variability in immune responses. In addition to its short-term impact on immunity, smoking also has long-term consequences. For...
-
News | 2022.10.17
Antifungal therapy: Csa6 protein, a potential target for treatment development
A team of scientists has revealed a gene (CSA6) that regulates genome stability in Candida albicans and other related fungi. The protein produced by this gene, Csa6, therefore represents a potential target for antifungal therapy, at a time when there is an urgent need for the development of novel treatments for fungal infections.
-
Document de presse | 2024.09.03
First sustained remission of HIV infection following a bone marrow transplant in the absence of protective mutation
Case of Geneva patient presented in the prestigious scientific journal Nature Medicine.A total of seven individuals worldwide (two patients in Berlin and patients in London, Düsseldorf, New York, City of Hope and Geneva) are considered likely to have been cured or to be in long-term remission of HIV infection after receiving a bone marrow transplant to treat blood cancer. Romuald, the Geneva...
-
News | 2024.06.10
The institut pasteur partners with the new exhibition at the musée des confluences in lyon: "epidemics, taking care of the living world"
From April 12, 2024 to February 16, 2025, the Musée des Confluences is hosting "Epidemics, taking care of the living world," an exhibition in which epidemics are viewed as both a biological and social phenomenon. We speak to anthropologist and project manager, Mathilde Gallay-Keller about this exhibition.
-
Document de presse | 2025.07.29
Long COVID: SARS-CoV-2 persists in the brainstem in the long term and deregulates neuronal activity
Symptoms can persist in some SARS-CoV-2 patients several months after infection. Scientists at the Institut Pasteur have demonstrated in an animal model that SARS-CoV-2 infects the brain and persists in the brainstem for up to 80 days after the acute infection phase. The presence of the virus is linked to symptoms of depression, impaired memory, and anxiety. Genes associated with neuronal...
-
Article | 2018.01.30
Perilic project: Studying the protection of pertussis vaccination
A unique study on whooping cough (pertussis), in three regions of the world, estimates the duration of protection from the various vaccinations against pertussis.
-
Article | 2017.10.13
Afribiota project: Childhood malnutrition
Malnutrition is a leading cause of child morbidity and mortality in low-income countries. The state of malnutrition is maintained by a chronic inflammation of the intestine observed in a large proportion of children living in unsanitary conditions. This syndrome called pediatric environmental enteropathy has so far been poorly studied. The Afribiota project aims to better characterize this...
-
Document de presse | 2026.03.02
How microbes protect against allergies
A study conducted by scientists from the Institut Pasteur has revealed that microbes protect the lungs from subsequently developing allergies and asthma. This long-term protection is "memorized" not by immune system cells but by fibroblasts, structural cells in the lungs. These results, published in Nature Immunology, open up new possibilities for the development of preventive strategies for...
-
Portrait | 2026.03.30
Guillemette Masse-Ranson: the scientist breaking down barriers within vaccine research
Guillemette Masse-Ranson, Deputy Director of the Institut Pasteur Vaccinology and Immunotherapy Center, combines industry experience with a passion for academic research. Her ambition is to revolutionize vaccine development by breaking down silos between disciplines, speeding up the transition from lab to clinical practice, and connecting the Institut Pasteur's scientists to international...